학술논문
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study
Document Type
Article
Author
Zambrotta, G.P.M.; Piazza, R.; Guglielmana, V.; Colombo, F.; Antolini, L.; Gambacorti-Passerini, C.; Nicolini, F.E.; Assouline, S.; Busque, L.; Pungolino, E.; Abruzzese, E.; Miggiano, M.C.; Elena, C.; Alvarez-Larran, A.; Triguero, A.; Iurlo, A.; Bucelli, C.; Cerrano, M.; Capodanno, I.; Lunghi, F.; le Coutre, P.; Galimberti, S.; Caocci, G.; Maffioli, M.; Stagno, F.; Saussele, S.; Druker, B.J.; Fava, C.
Source
In: American Journal of Hematology . (American Journal of Hematology, November 2023, 98(11):1762-1771)
Subject
Language
English
ISSN
10968652
03618609
03618609